AI for strategic decisions
A research agent built for competitive intelligence
- ThinkingReading the question
- ScopingChecking what it holds
- PlanningDrafting six sections
- QueryingPulling the numbers
- WritingDrafting the analysis
- DoneReport ready
Who is already running ADC trials in gastric cancer
Example: 112 trials · 46 companies · measured Oct 5, 2026
| Daiichi Sankyo / AstraZeneca | 14 |
| Zymeworks | 9 |
| RemeGen | 7 |
| Seagen | 5 |
Phase 1 → Phase 3. Every table carries the count behind it.
Serious competitive analysis and development strategy, within anyone's reach
Big pharma has whole departments for competitive intelligence. At a drug discovery startup, the leadership team does that work between everything else. Competing assets to research, development strategy to weigh, a target product profile to refine: the questions never run out, but nobody has time to learn their way around the big commercial databases. A general-purpose AI doesn't give comprehensive answers, and checking whether they are right takes up yet more time.
An AI agent backed by comprehensive data
Strategy starts from the big picture: which targets are overcrowded, which assets are ahead in development, and which startups are building technology that competes with yours. The AI agent draws quantitative insight from comprehensive, curated data on pipeline assets, clinical trials, the platform technologies of drug discovery startups and more.
Analysis frameworks built from real practice
No more trial-and-error prompting, or asking an AI “Is that everything?” again and again. The AI agent works from 109 predefined analysis templates, visualizing the data and interpreting it the way an expert analyst would. All you have to do is ask what you want to know.
Correct data, so you can focus on the decision
A general-purpose AI mixes plausible-sounding errors (hallucinations) into its answers, and reviewing the data takes up much of your time. The AI agent is built to write its reports from curated data, so you can concentrate on interpretation and decisions. When you want to dig deeper, ask the agent a follow-up question, or download the report and hand the analysis over to the AI you already use.
Use cases
Each of these starts from an example button on the app's home screen. The button puts the question into the input box, and you can rewrite it for your own field before you send it.
Trend analysis
Counts the pipeline assets, trials, deals and companies in a field, and shows the trend by year, the spread across development stages and who is ahead, in tables and charts.
Draft a TPP
Builds a target product profile (TPP) draft table in a discussion. Enter the indication, and a reference table is assembled from our data automatically; you write the targets yourself.
Explore by disease
Sorts the pipeline assets and companies for a disease by stage and modality, alongside patient numbers in Japan and the standard of care from our sourced disease primers.
Target competition
Lines up pipeline assets and their developers target by target, and compares by development stage which targets are crowded and how far each has progressed.
Compare technologies
Classifies company platform technologies by method and target with our hand-built vocabulary, and compares which companies compete with which approach.
Partnerships
Lists deals between companies by type, partner and timing, showing which companies big pharma is teaming up with.
Trial design
Tallies phase, control-arm type, primary endpoint category and eligibility criteria across registered trials, showing how trials in the field tend to be designed.
Conference results
Lines up result figures taken from major conference abstracts, such as response rates, median survival and hazard ratios, trial by trial. Figures have been extracted for some abstracts only.
Pricing
The prices and free trial shown here are planned for when you can sign up and subscribe on your own. For now, AGcollectio is available by invitation only.
Everything, one plan
$790
a year, billed annually — or $79 a month
The base fee includes $79 of usage each month, and anything beyond that is billed by usage. Unused credit doesn't roll over to the next month. You get unlimited seats, so the whole team can use it with no per-seat charge.
No card needed, 30 days to use it. The trial doesn't switch to a paid plan on its own.
What work costs
- A full report~$5
- A follow-up question~$0.17
- A question that needs the open web~$0.60
- Re-cutting numbers$0
- Downloading a report$0
You can set a monthly limit to keep usage in check. By default the limit is the base fee's $79, so unless you change it, you are never billed more than the monthly (or yearly) price. If an organization admin raises the limit, usage beyond the base fee's allowance is billed by usage.
AGcollectio is currently available by invitation only. If you would like to use it, please get in touch through our contact page.